Earnings Feed
Start Free
Hims & Hers Health, Inc.·4

Jun 17, 6:50 PM ET

Elshenawy Mohamed 4

Research Summary

AI-generated summary

Updated

Hims & Hers (HIMS) CTO Mohamed Elshenawy Sells Shares

What Happened

  • Mohamed Elshenawy, Chief Technology Officer at Hims & Hers (HIMS), reported the vesting/settlement of RSUs and subsequent share dispositions. On June 15, 2026, 282,597 RSUs were converted/settled. To cover tax withholding obligations, 151,534 shares were withheld by the issuer (value reported $4,571,781). On June 17, 2026, Elshenawy sold 30,040 shares in an open-market transaction at $31.50 per share for proceeds of $946,260. The filing also reports additional derivative-related settlements of 259,084 and 23,513 shares (reported with $0 exercise price, reflecting RSU settlement).

Key Details

  • Transaction dates and prices:
    • June 15, 2026: RSU vest/settlement (282,597 RSUs converted); 151,534 shares withheld for taxes at implied value $30.17 ($4,571,781).
    • June 17, 2026: Open-market sale of 30,040 shares at $31.50 ($946,260).
    • Additional RSU/derivative settlements of 259,084 and 23,513 shares reported at $0.00 (reflecting RSU settlement).
  • Combined reported value related to these actions: approximately $5.52M (withheld value + sale proceeds).
  • Shares owned after the transactions: not specified in the provided filing.
  • Notable footnotes:
    • F1/F4/F5: These were RSUs (one RSU = one share) subject to a 4‑year service-based vesting schedule with an initial vest on June 15, 2026 and subsequent quarterly vesting.
    • F2: The 151,534 shares were withheld by the issuer to satisfy tax-withholding obligations.
    • F3: The open-market sales were executed under a Rule 10b5-1 trading plan adopted December 1, 2025.
  • Filing timeliness: Reported on Form 4 filed June 17, 2026 for transactions occurring June 15–17, 2026 (appears timely).

Context

  • These entries reflect RSU vesting and settlement (derivative conversions) followed by routine tax withholding and a planned sale under a 10b5-1 plan. RSU settlements reported at $0.00 exercise price indicate no option exercise cost (they were awarded as RSUs and converted to shares).
  • Tax-withheld shares are not a market-sale by the insider but a net settlement to cover withholding. The open-market sale is a realized disposition and was executed under a pre-established trading plan.
  • This is standard executive compensation activity rather than an outright purchase; purchases are generally more informative as bullish signals.